17Aug
An Update on Poison Pills, NOL Poison Pills and the COVID-19 Pandemic
Since the release of our recent article “Poison Pills, NOL Poison Pills and the COVID-19 Pandemic” in midApril, we continue to see a surge in the number of companies implementing poison pills (also referred to as shareholder rights plans), a type of defensive tactic used by a corporation’s board of directors against a hostile takeover bid. Please see full Publication below for more information....
By:
Robinson & Cole LLP
Related
Doe v. Department of Corr. & Rehab., 2019 WL 6907515 (Cal. Ct. App. 2019) - John Doe, who worked a...
Read More >
BCLP’s global Antitrust & Competition team have been tracking the various ways COVID-19 is impactin...
Read More >
Rhode Island is the latest state to jump on the bandwagon of limiting the application of non-compete...
Read More >
UK Case Law Developments - Valid notice crucial to tax indemnity claim - The Court of Appeal (CA...
Read More >
A recent High Court ruling in the case of R (Swire) v Secretary of State [2020] has highlighted the ...
Read More >
The DE OFCCP Week in Review (WIR) is a simple, fast and direct summary of relevant happenings in the...
Read More >